Clinical Trial Update: Valproic Acid for Idiopathic Nephrotic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on valproic acid for idiopathic nephrotic syndrome, with Phase 2 and Phase 3, including mention of focal segmental glomerulosclerosis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis
• Idiopathic Nephrotic Syndrome
• Minimal Change Disease

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Phase 2, Phase 3 | Status: UNKNOWN